Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Designer glucocorticoids.

Jeffrey N Miner1

  • 1Department of Molecular and Cellular Biology, Ligand Pharmaceuticals, 10275 Science Center Drive, San Diego, CA 92121, USA. jminer@ligand.com

Biochemical Pharmacology
|July 31, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Role of Hepatic Stellate and Liver Sinusoidal Endothelial Cells in a Human Primary Cell Three-Dimensional Model of Nonalcoholic Steatohepatitis.

The American journal of pathology·2023
Same author

Multimodal NASH prognosis using 3D imaging flow cytometry and artificial intelligence to characterize liver cells.

Scientific reports·2022
Same author

Systematic genetic analysis of early-onset gout: ABCG2 is the only associated locus.

Rheumatology (Oxford, England)·2020
Same author

No association between ATP-binding cassette transporter G2 rs2231142 (Q141K) and urate-lowering response to febuxostat.

Rheumatology (Oxford, England)·2019
Same author

Characterization of Stereoselective Metabolism, Inhibitory Effect on Uric Acid Uptake Transporters, and Pharmacokinetics of Lesinurad Atropisomers.

Drug metabolism and disposition: the biological fate of chemicals·2018
Same author

ABCG2 rs2231142 (Q141K) and oxypurinol concentrations in people with gout receiving allopurinol.

Drug metabolism and pharmacokinetics·2018

Glucocorticoids are potent anti-inflammatory drugs, but cause severe side effects. Research is exploring novel steroidal and non-steroidal compounds for safer, next-generation anti-inflammatory therapies.

Area of Science:

  • Pharmacology
  • Medicinal Chemistry
  • Inflammation Research

Background:

  • Glucocorticoids are highly effective anti-inflammatory agents.
  • Their clinical use is limited by significant, potentially life-threatening side effects.

Purpose of the Study:

  • To explore novel compounds with anti-inflammatory properties.
  • To identify next-generation glucocorticoids with improved safety profiles.

Main Methods:

  • Investigating novel steroidal compounds.
  • Developing new non-steroidal anti-inflammatory agents.
  • Evaluating compound efficacy and safety profiles.

Main Results:

  • Emerging novel steroidal and non-steroidal compounds show promise.

Related Experiment Videos

  • These new agents possess unique profiles for potential therapeutic use.

    • Conclusions:

    • New approaches are yielding next-generation anti-inflammatory compounds.
    • These novel molecules may offer safer alternatives to current glucocorticoids.